Bringing Effective Solutions through Psoriasis Clinical Trials

Around 2-3% of the world’s population suffers from the common skin ailment plaque psoriasis. It shows up as an overproduction of skin cells, leading to the development of thicker, flaming red plaques. It manifests as an excessive production of skin cells, resulting in the formation of thickened, red plaques accompanied by inflammation. In addition to its impact on the skin, plaque psoriasis can extend its influence on the joints, leading to a potentially debilitating form of arthritis causing pain and reduced mobility. At MetroBoston, we are at the forefront of conducting clinical trials focused on plaque psoriasis. Our primary objective is to enhance our understanding of this condition and to develop potential innovative approaches to improve the lives of individuals affected by plaque psoriasis. Our Psoriasis Clinical Trials are dedicated to improving the management of this condition and enhancing the overall quality of life for those affected by it.